1. Introduction {#sec1}
===============

Reversible phosphorylation of serine, threonine, and tyrosine residues is one of the most common and important regulatory posttranslational modifications of proteins and plays a crucial role in many biological processes, including cellular signal transduction, regulation of enzyme activities, metabolic regulation, molecular recognition and biomolecular interaction, protein localization, cell differentiation and proliferation \[[@B1]--[@B5]\]. Therefore, identifying phosphorylated proteins is an important step to elucidate the structural and functional role of the protein\'s phosphorylation regulation.

Up to now, mass spectrometry, including matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) and electrospray ionization mass spectrometry (ESI-MS) have been key technologies in characterizing protein phosphorylation and phosphoproteome, and each approach presented strengths and limitations \[[@B6]--[@B15]\]. However, because of the low and dynamic stoichiometry of phosphorylation on proteins \[[@B16], [@B17]\] and the low ionization efficiency of phosphopeptides, it remains challenging to thoroughly characterize phosphorylation sites using mass spectrometry \[[@B18]\]. Considerable effort has been made recently to improve the ionization efficiency of phosphopeptides by selecting and optimizing appropriate matrices with MALDI-TOF-MS. Several materials have been employed in phosphopeptide analysis, including 2, 5-dihydroxybenzoic acid (DHB) \[[@B19]--[@B25]\], 2, 4, 6-trihydroxyacetophenone (THAP) \[[@B20]\], and ionic liquid matrices \[[@B21]\]. In addition, ammonium salts, including diammonium hydrogen citrate (DAHC) \[[@B20]--[@B23]\], ammonium acetate \[[@B22]\] and monoammonium phosphate \[[@B24]\], and phosphoric acid \[[@B19]--[@B25]\] have been used as matrix additives and have shown some ability to enhance phosphopeptide ionization during MALDI-TOF-MS.

2, 6-Dihydroxyacetophenone (DHAP) was first used by Gorman et al. as a matrix for MALDI analysis of fragile peptides, disulfide bonding, and small proteins, including phosphopeptides \[[@B23]\]. In recent years, Xu et al. reported that the DHAP/DAHC matrix combination was used as an effective MALDI matrix in detecting methyl esterified phosphopeptides by MALDI-TOF-MS \[[@B26], [@B27]\]. After systematic optimization in this study, we found that contrary to previous reports, the matrix forms at a lower ratio of DHAP/DAHC and that this ratio shows greater efficiency in improving ionization ability of phosphopeptides. We investigated the characteristics of an optimal DHAP/DAHC matrix, and analyzed morphology and detection sensitivity of phosphopeptides. Using tryptic digests of *α*- and *β*-casein, we demonstrated a CID MS/MS analysis of phosphopeptides by MALDI-TOF/TOF-MS with an optimized DHAP/DAHC matrix. Finally, we used this approach to analyze phosphorylation sites on human histone H1 treated with Cyclin-Dependent Kinase-1 (CDK1).

2. Experimental {#sec2}
===============

2.1. Materials {#sec2.1}
--------------

The chemicals 2, 6-dihydroxyacetophenone (DHAP), 2, 5-dihydroxy-benzoic acid (DHB), diammonium hydrogen citrate (DAHC), ammonium bicarbonate, trifluoroacetic acid (TFA), alkaline phosphatases, *α*-casein and *β*-casein (both from bovine milk, purity by electrophoresis) were all purchased from Sigma Aldrich (St. Louis, MO, USA). Cyclin-Dependent Kinase-1(CDK1) and human histone H1 were purchased from New England BioLabs, Inc. The standard peptides VNQIG**p**TLSESIK (**p**T, purity \> 95%) and SGSLHRI**p**YTHQS (**p**Y, purity \> 85%) were synthesized in Beijing Scilight Biotechnology Ltd. Co. (Beijing, China). Sequencing grade modified trypsin (porcine) was purchased from Promega Co. (Madison, WI, USA). HPLC-grade acetonitrile and acetic acid were purchased from Mallinckrodt Baker, Inc, (Phillipsburg, NJ, USA). Ethanol and ammonium hydroxide solutions (NH~3~ · H~2~O) were purchased from Beijing Chemical Company (Beijing China); ultrapure water was obtained from a Milli-Q system (Millipore, Bedford, MA, USA). All other chemicals used were of ACS or HPLC grade.

2.2. Matrix Preparation {#sec2.2}
-----------------------

A 20-mg/mL dilution of DAHC stock solution was prepared with ultrapure water. The DHAP matrix stock solution was prepared by dissolving 10 mg of DHAP in 1 mL of anhydrous ethanol. A series of modified DHAP/DAHC matrix solutions were prepared by mixing DHAP stock solution with DAHC stock solution at different ratios from 10  :  1 to 1  :  80 (v/v). The DHB/phosphoric acid (PA) matrix was prepared as previously reported \[[@B19]\]; we modified this previous protocol by dissolving 20 mg of DHB in 1 mL of 50% aqueous acetonitrile containing 1% phosphoric acid.

2.3. Sample Preparation {#sec2.3}
-----------------------

*α*-Casein and *β*-casein (100 nM in 50 mM ammonium bicarbonate buffer at pH 8.3) were digested overnight at 37°C with trypsin at an enzyme/substrate ratio of 1  :  25 (w/w). After digestion, TFA was added into the sample solution at 1.0% to quench the reaction. The digest was diluted with 60% acetonitrile containing 0.1% TFA to produce a series of sample solutions at concentrations of 1 pmol/*μ*L, 200 fmol/*μ*L, 50 fmol/*μ*L, 20 fmol/*μ*L, and 10 fmol/*μ*L. A stock solution containing standard peptides **p**T (1 mM) and **p**Y(1 mM) was prepared using ultra pure water. The solution was diluted with 60% acetonitrile containing 0.1% TFA to 1 pmol/*μ*L, 200 fmol/*μ*L, 50 fmol/*μ*L, 20 fmol/*μ*L, and 10 fmol/*μ*L. All of the peptide solutions prepared for DHB/PA measurements were diluted with 1% phosphoric acid.

2.4. Human Histone H1 Phosphorylation and Digestion {#sec2.4}
---------------------------------------------------

The phosphorylation reaction between histone H1 and CDK1 was carried out in vitro. Briefly, the reaction solution was prepared with 3 *μ*L 10 × CDK1 reaction buffer, 0.15 *μ*L CDK1 (150 U), 4 *μ*L histone H1 (1 *μ*g/*μ*L), 100 *μ*M ATP, and 13 *μ*L water, then incubated at 30°C for 45 minutes. The phosphorylated histone H1 was then separated using SDS-PAGE (12%) and stained with Coomassie Brilliant Blue using microwave-assisted methods \[[@B28]\]. The in-gel digestion of phosphorylated histone H1 was performed as follows: the band of histone H1 was excised from the polyacrylamide gel, washed twice with water, and destained with 40% acetonitrile/50 mM NH~4~HCO~3~. The gel pieces were dehydrated with 100% acetonitrile and dried for 5 min using a speedvac. Disulfide bonds were reduced with DTT (10 mM, 56°C, 45 minutes), and the free sulfhydryl groups were alkylated with iodoacetamide (55 mM, 25°C, 60 minutes in the dark). Gel pieces were washed with 50 mM NH~4~HCO~3~, 50% acetonitrile/50 mM NH~4~HCO~3~, and dehydrated with 100% acetonitrile. After drying with a speedvac, the gel was rehydrated using 100 ng/*μ*L trypsin (50 mM NH~4~HCO~3~, pH 8.3) on ice for 30 minutes, and the digestion was carried out at 37°C for 60 minutes and then quenched with 1.0% TFA. The tryptic peptides were extracted twice with 60% acetonitrile containing 0.1% TFA, and then the combined digest solution was concentrated to 10 *μ*L under vacuum.

2.5. Sample Analysis by MALDI-TOF-MS and MALDI-TOF2-MS {#sec2.5}
------------------------------------------------------

MALDI-TOF-MS analysis of peptides was performed using an AXIMA-CFR *plus* MALDI-TOF mass spectrometer (Shimadzu/Kratos, Manchester, UK) equipped with a pulsed nitrogen laser operated at 337 nm. Positive/negative ion MALDI mass spectra were acquired in the reflectron mode under the following parameters: ion source, 20/−20 kv, lens, 6.3/−6.3 kv, pulsed extraction, −2.5/2.5 kv, reflection, 25/−25 kV. High-energy CID MS/MS was performed with the AXIMA-TOF^2^ MALDI mass spectrometer (Shimadzu/Kratos, Manchester, UK), equipped with the same pulsed 337-nm nitrogen laser. Operation parameters were: ion source, 20.0 kV; lens, 6.5 kV; pulsed extraction, −2.5 kV; and reflectron, 24.4 kV.

To prepare for MALDI-TOF-MS analysis, 1 *μ*L of peptide solution was mixed with 3 *μ*L of matrix solution in an Eppendorf tube, and 1 *μ*L of the peptide/matrix solution was spotted onto the MALDI sample plate and then crystallized either under vacuum (when DHAP/DAHC was used as matrix) or in the air (when DHB/PA was used as matrix). Measurements using DHAP/DAHC were performed by detecting 15--20 different positions on the broad outer zone (see discussion below) for each sample to accumulate a total of 200 profiles (5 shots per profile). For measurements with DHB/PA, a total of 200 profiles (5 shots per profile) were accumulated by searching for 10--15 hot spots for each sample. All experiments were repeated three times.

The standard peptide **p**T (250 fmol on target) was used to determine sample homogeneity of the matrix. On each sample spot, 196 (14 × 14) positions were selected manually to ensure a full overview over the sample preparation. For each position, 50 profiles (5 shots per profile) were accumulated in positive ion mode. The signal intensities of **p**T in each position were recorded for further analysis.

Mass spectrometry data were processed with Launchpad 2.7.1 software (Shimadzu/Kratos, Manchester, UK). The data of the CID MS/MS spectra of phosphopeptides from histone H1 were compared to the SwissProt 56.6 protein sequence database (*Homo sapiens*) using the on-line MASCOT database search engine (Matrix Science, London, UK) with the following parameters: trypsin with three missed cleavages; average mass values; peptide mass tolerance: ±0.8 Da; fragment mass tolerance: ±1.0 Da; fixed modifications: Carbamidomethyl (C), variable modifications: Oxidation (M), phosphor (ST). Only the peptides with ions score above 38 were accepted as significant matches.

3. Results and Discussion {#sec3}
=========================

3.1. Optimization of DHAP/DAHC Matrix Combination {#sec3.1}
-------------------------------------------------

The solution composition of the matrix is a factor that significantly influences the ionization efficiency and the quality of MALDI mass spectra \[[@B29]\]. Therefore, we prepared a series of different ratios of DHAP (10 mg/mL) and DAHC (20 mg/mL) matrix solutions (10 : 1, 5 : 1, 1 : 1, 1 : 4, 1 : 8, 1 : 16, 1 : 20, 1 : 30, 1 : 40, 1 : 50, 1 : 60, and 1 : 80 v/v) and investigated these matrix combinations using the tryptic digest of *α*-casein, which contains nine phosphopeptides (T*α*1-T*α*9) and some nonphosphopeptides (such as T4, T10, T11, T18) (see [Table 1](#tab1){ref-type="table"}).[Figure 1](#fig1){ref-type="fig"}shows a comparison of the MALDI-TOF-MS analysis of the tryptic digest of *α*-casein (250 fmol on target) using matrix DHAP/DAHC at different ratios in positive ion mode. The signal intensity of phosphopeptides (especially for multiple phosphorylated peptides) changed dramatically with the ratio of DHAP/DAHC. It was clear that all phosphopeptides could be easily detected with a low DHAP/DAHC matrix ratio in the range of 1 : 30 to 1 : 60. In an optimal matrix solution, the concentration of DHAP was 1.6--3.3 mg/mL, which is lower than the concentration of 10--15 mg/mL used by other groups \[[@B23], [@B26], [@B27]\]. Once the DHAP/DAHC ratio was down to 1 : 80, most multiple phosphorylated peptides could no longer be detected, likely because there were not sufficient numbers of DHAP molecules to transfer the laser energy to the peptides to be protonated.

Another interesting phenomenon apparent in [Figure 1](#fig1){ref-type="fig"}: the signal intensity of nonphosphopeptides was stable (T3), enhanced (T10) or weakened (T11, T4, T18) with the change of the DHAP/DAHC ratio. We calculated the Bull and Breese Index (BB Index) \[[@B19]\] of these peptides, an index generally used to reflect the hydrophobic/hydrophilic nature of peptides. Higher BB Index values are associated with more hydrophilic peptides. For the phosphopeptide, we calculated the BB Index by replacing the phosphoserine or phosphothreonine residues with glutamic acid \[[@B19]\]. By comparing the BB Index of peptides listed in [Table 1](#tab1){ref-type="table"}, we found that the phosphopeptides were nearly hydrophilic peptides with high BB Indices and that the nonphosphopeptides for which signal intensity was weakened at low DHAP/DAHC ratio were highly hydrophobic with lower BB Index (T4 :  −5530, T11 : −6480, T18 : −6900). The nonphosphopeptide T10 for which the ion signal was enhanced at lower ratios of DHAP/DAHC was found to be slightly hydrophobic with a BB Index of −750. These findings indicated that the optimal DAHC/DHAP matrix tended to detect more hydrophilic peptides. Most phosphopeptides are hydrophilic, so we propose that the low ratio of DHAP/DAHC matrix could increase cocrystallization between matrix and phosphopeptides and further improve ionization efficiency of phosphopeptide in MALDI MS.

3.2. Sample Homogeneity {#sec3.2}
-----------------------

In this study, the phosphopeptide **p**T (250 fmol on target) was used to investigate the sample homogeneity of optimized DHAP/DAHC matrix, and for a comparison, we chose matrix combination of 2,5-DHB with 1% phosphoric acid, a currently popular matrix used for detection of phosphopeptide \[[@B30]--[@B32]\]. It was apparent from the photographs of the MALDI sample spots that there was a dramatic difference between the optimized DHAP/DAHC ([Figure 2(a)](#fig2){ref-type="fig"}) and DHB/PA ([Figure 2(b)](#fig2){ref-type="fig"}). Small crystals formed in a DHAP/DAHC sample spot while larger, needle-like crystals formed in a DHB/PA sample spot. Furthermore, 196 (14 × 14) positions on the target were measured covering the crystalline layer for a full overview ([Figure 2(e)](#fig2){ref-type="fig"}), and the MS signal intensities of pT were monitored. The majority of the outer zones of the crystalline samples exhibited high signal intensities, except for a small center zone when DHAP/DAHC used as matrix ([Figure 2(c)](#fig2){ref-type="fig"}). In comparison, the crystalline DHB/PA matrix exhibited the hot-spot phenomenon, signals were primarily observed in the narrow, inhomogeneous ring at the edge of the sample layer, and the inner position almost did not exhibit any signal ([Figure 2(d)](#fig2){ref-type="fig"}). Therefore, the samples prepared with DHAP/DAHC were more homogeneous than those prepared with a DHB/PA matrix, reducing the need for time-consuming hot-spot searches. Based on the sample homogeneity of DHAP/DAHC and DHB/PA, in the next experiments, the data acquisition with DHAP/DAHC was carried out by randomly measuring the outer zone of the sample layer, while data were acquired from the DHB/PA matrix by searching for hot spots of sample.

3.3. Sensitivity Measurement of Phosphopeptides with the DHAP/DAHC Matrix {#sec3.3}
-------------------------------------------------------------------------

In order to further evaluate the measurement sensitivity of phosphopeptides with the optimal DHAP/DAHC matrix, the tryptic digest of *α*-casein and *β*-casein with 2.5--250 fmol on the target were detected by MALDI-TOF MS in both positive and negative ion mode.[Figure 3](#fig3){ref-type="fig"}shows that all eleven phosphopeptides from *α*-casein and *β*-casein could be detected with signal-to-noise (S/N) ratios greater than 3 at the low amount of 12.5 fmol in the positive mode (a) and (b) and detected at a lower amount of 5 fmol in the negative mode (c) and (d). The monophosphopeptides (T*α*1 and T*β*1) could still be observed at 2.5 fmol on target in negative ion mode ([Figure 3(c)](#fig3){ref-type="fig"}). Phosphopeptides generally exhibited better S/N ratios in the MS spectra in negative ion mode than that in positive ion mode, although, consistent with previous reports \[[@B19]\], the absolute signal intensity of phosphopeptide was usually lower in negative ion mode. Because all tryptic phosphopeptides from *α*-casein and *β*-casein are serine-phosphorylated peptides, a threonine-phosphorylated peptide **p**T and a tyrosine-phosphorylated peptide **p**Y (2.5--250 fmol on target) were used to investigate whether the DHAP/DAHC matrix had a generic nature in detection of phosphopeptides. As expected, **p**T and **p**Y could be readily detected down to 5 fmol on the target in both positive and negative modes ([Figure 4](#fig4){ref-type="fig"}).

We further directly compared optimized DHAP/DAHC to DHB/PA. Tryptic digests of *α*-casein and *β*-casein (12.5--250 fmol on target) were detected using these two matrices ([Figure 5](#fig5){ref-type="fig"}). When using the DHAP/DAHC matrix, all the phosphopeptides could readily be detected at three different sample amounts. By comparison, when DHB/PA was used as the matrix, although all the phosphopeptides in 250 fmol digest (on target) could be detected with DHB/PA, the amount of digest went down to 50 fmol (on the target), and only T*α*1, T*α*2, T*α*3, T*α*6, T*β*1, and T*β*2 could be observed. Furthermore, when the amount of digest went down to 12.5 fmol, only T*α*1 and T*β*1 were detected, with weak signals. Comparing these results, it was clear that compared with DHB/PA, the optimized DHAP/DAHC had comparative sensitivity in the detection of singly phosphorylated peptides (T*α*1 and T*β*1), but greater sensitivity in the detection of multiply phosphorylated peptides, such as T*β*2 (4**p**) and T*α*4 (5**p**). Herein, we suggest that sample should be analyzed immediately after sample preparation when optimized DHAP/DAHC matrix used, as the crystals might not last too long under atmospheric conditions and in vacuo.

3.4. Sequencing of Phosphopeptides with High Energy CID MS/MS {#sec3.4}
-------------------------------------------------------------

We employed the AXIMA-TOF^2^ MALDI mass spectrometer (Shimadzu/Kratos, Manchester, UK) to perform high energy CID MS/MS of phosphopeptides to characterize phosphorylation sites.[Figure 6](#fig6){ref-type="fig"}shows the MS/MS spectra of three phosphopeptides T*β*1, T*α*3, and T*β*2 from *α*-casein and *β*-casein (250 fmol on target) with DHAP/DAHC as matrix. The number of \[MH-98\]^+^ or \[MH-80\]^+^ peaks in the MS/MS spectra indicated the number of phosphate groups in each phosphorylated peptide, and the fragment ions including *a*, *b,*and *y* ions clearly show the phosphorylation sites of the phosphopeptides T*β*1, T*α*3, and T*β*2. These results demonstrated the feasibility of MALDI-TOF/TOF MS with the DHAP/DAHC matrix for the analysis of the phosphorylation sites of phosphopeptides, including singly and multiply phosphorylated peptides.

3.5. Application of the Optimized DHAP/DAHC Matrix in the Characterization of Phosphorylated Human Histone H1 {#sec3.5}
-------------------------------------------------------------------------------------------------------------

Further investigating the practicality of the DHAP/DAHC matrix, we used this approach to characterize human histone H1 phosphorylated with CDK1. Experimentally, phosphorylated histone H1 was separated by SDS-PAGE and in-gel digested by trypsin. In order to generate appropriate peptide sizes for MALDI-MS analysis, since the sequence of histone proteins is known to contain many lysine and arginine residues, the trypsin digestion time was optimized and reduced to 1 hour.[Figure 7](#fig7){ref-type="fig"}(a) shows the results of the MALDI-TOF-MS analysis of the tryptic digest of the phosphorylated histone H1 without the desalting step, directly detected with the optimized DHAP/DAHC matrix in positive ion mode. After performing data processing using the on-line MASCOT search engine, 31 peptides, including 2 possible phosphopeptides (in [Figure 7(a)](#fig7){ref-type="fig"} labeled with "\*"), were assigned to human histone H1, and 81% of the sequence was covered. These two peptides corresponded to the two monophosphopeptides of histone H1, comprising amino acids 117--127 (VA[T]{.ul}PKKA[S]{.ul}KPK, 1234.7 m/z; possible phosphorylation sites indicated with underlined letters) and 133--145 (AP[T]{.ul}KKPKA[T]{.ul}PVKK, 1473.9 m/z). The tryptic sample of H1 was also analyzed with DHB/PA, but the two peaks of the phosphopeptide were lower than those in [Figure 7(a)](#fig7){ref-type="fig"} (see Figure S1). To validate the MASCOT searching result for the two phosphorylated peptides, we compared the mass spectra of tryptic peptides of H1 before and after treatment with alkaline phosphatase, which can cleave the phosphate group from phosphopeptides. It was clear that the two peptide peaks (marked with asterisks in [Figure 7(a)](#fig7){ref-type="fig"}) had disappeared and two new peaks with a mass shift of 80 Da (HPO~3~ = 80 Da) were visible ([Figure 7(b)](#fig7){ref-type="fig"}). This demonstrated that the two peptides (marked with asterisks in [Figure 7(a)](#fig7){ref-type="fig"} were singly phosphorylated peptides. To identify the phosphorylation sites, we used MALDI-TOF/TOF MS to perform MS/MS analysis of the two peptides ([Figure 7(c)](#fig7){ref-type="fig"} and [7(d)](#fig7){ref-type="fig"}). Only one neutral-loss peak corresponding to \[MH-H~3~PO~4~\]^+^ indicated that both phosphopeptides were monophosphopeptides. After a MASCOT search, the phosphorylation sites of the two phosphopeptides were determined to be APTKKPKApTPVKK (pT indicating the phosphothreonine) and VApTPKKASKPK with ion scores of 53 and 50, respectively (scores exceeding 38 were accepted as significant matches).

In general, the protein phosphorylation sites by a particular protein kinase shared a set of "consensus sequence", which is necessary and sufficient for recognition by the kinase \[[@B33]\]. To further validate the phosphorylation sites of histone H1 identified with MALDI-TOF/TOF MS, we compared the two phosphorylated peptide sequences with the consensus sequence pS/pT-P-X-R/K, most frequently recognized by CDK1 \[[@B34], [@B35]\], and found that both phosphopeptide sequences were consistent with the consensus sequence. These results thus demonstrate that the DHAP/DAHC matrix was robust and effective in analyzing the protein phosphorylation of the biological sample by MALDI-MS.

4. Conclusion {#sec4}
=============

By optimizing the matrix solution composition, we found that a low ratio of DHAP/DAHC formulation was more efficient in detecting phosphopeptides than earlier protocols. Compared with DHB/PA, the optimized DHAP/DAHC exhibited higher sample homogeneity, and the phosphopeptides in tryptic digests of *α*- and *β*-casein without desalting and phosphopeptide enrichment could be measured with a higher sensitivity. Further, the optimized DHAP/DAHC showed high energy CID MS/MS analysis of the phosphorylation sites of phosphopeptides, including multiple phosphorylated peptides, and we successfully applied this method to the characterization of the phosphorylation sites of CDK1-treated human histone H1.
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![The MALDI mass spectra of the tryptic digest of *α*-casein (250 fmol on target) measured in positive ion mode with DHAP/DAHC matrix at different ratios (10 : 1 to 1 : 80). The signal intensity is magnified 10-fold in the m/z range from 2575 to 3025. The number of sites on each phosphopeptide is equal to the number of asterisks (\*) shown.](JBB2010-759690.001){#fig1}

![Top two views show the MALDI samples containing the phosphopeptide **p**T using (a) DHAP/DAHC matrix and (b) DHB/PA matrix. The two center pictures show the signal intensities of the phosphopeptides **p**T (250 fmol on target) measured with (c) DHAP/DAHC matrix and (d) DHB/PA matrix. The images only show a cut at signal intensity of 400 mv for clarity. The positions with signal intensities above 400 mv are indicated in purple. The bottom row (e) shows a schematic of the data acquisition method for investigating sample homogeneity of the matrix. In total, 196 positions were selected as a 14 × 14 spots array to cover the crystalline matrix/analyte layer, and 50 profiles (5 shots per profiles) were accumulated at each position.](JBB2010-759690.002){#fig2}

![The MALDI mass spectra of the tryptic digest of (a) and (c) *α*-casein and (b) and (d) *β*-casein measured in positive (upper) and negative (lower) ion modes with the DHAP/DAHC matrix. The amount of the tryptic peptides mixture ranged from 5 fmol to 250 fmol on target. The signal intensity is magnified 5-fold in the m/z range from 2400 to 3150 in section a.](JBB2010-759690.003){#fig3}

![The MALDI mass spectra of two synthesized phosphopeptides **p**T and **p**Y mixed at equimolarity from 5 to 250 fmol on target, which were measured in positive (a) and negative (b) ion mode with DHAP/DAHC, respectively.](JBB2010-759690.004){#fig4}

![Tryptic digests of *α*- (upper) and *β*-casein (lower) (12.5--250 fmol on target) were detected with DHAP/DAHC (a) and (c) and DHB/PA (b) and (d) by MALDI-TOF MS in positive mode. DHAP/DAHC positions were selected randomly in the outer ring of the sample; for DHB/PA, only signals in hot spots were collected. In total, 200 profiles were accumulated for each sample. The number of sites on each phosphopeptide was equal to the number of asterisks (\*).](JBB2010-759690.005){#fig5}

![The MALDI MS/MS spectra of phosphopeptides (a) T*β*1, (b) T*α*3, and (c) T*β*2 (250 fmol for each on target) from *α*-casein and *β*-casein were obtained by MALDI-TOF/TOF MS. The sequential losses of H~3~PO~4~ from the parent ions are noted. The fragment patterns of the peptides are indicated in the magnified MS/MS spectra. "**X**" in the amino sequence shows a dehydroalanine residue converted from a phosphoserine residue by beta-elimination of H~3~PO~4~.](JBB2010-759690.006){#fig6}

![The MALDI MS analysis of phosphopeptides from CDK1-treated human histone H1. MS spectra of the tryptic peptides from CDK1-treated histone H1 with the untreated ([Figure 7(a)](#fig7){ref-type="fig"}) and alkaline phosphatase-treated histone H1 ([Figure 7(b)](#fig7){ref-type="fig"}). The two panels on the right show the magnified spectra to indicate the two phosphopeptides labeled with asterisks (\*). The MALDI-TOF/TOF-MS analysis of phosphorylation sites on the two monophosphopeptides VApTPKKASKPK, m/z 1234.7 (c), APTKKPKApTPVKK, m/z 1473.9 (d) from the CDK1-treated human histone H1. The neutral-loss peak of phosphopeptide was noted as \[MH-H~3~PO~4~\]^+^. The fragment patterns of peptides were shown in the magnified MS/MS spectra. "B" in the amino sequence indicates a dehydroamino-2-butyric acid residue converted from a phosphothreonine residue by beta-elimination of H~3~PO~4~. All the spectra were detected using DHAP/DAHC matrix in the positive mode.](JBB2010-759690.007){#fig7}

###### 

The peptides investigated in this study\*.

  Peptide ID   Sequence No.   Sequence                                 \[M+H\]~Theo~^+^   B+B
  ------------ -------------- ---------------------------------------- ------------------ -------
  T*α*1        aa 106--119    VPQLEIVPN**pS**AEER                      1660.79            260
  T*α*2        aa 104 --119   KYKVPQLEIVPN**pS**AEER                   1951.95            −710
  T*α*3        aa 43--58      DIG**pS**E**pS**TEDQAMEDIK               1927.68            3960
  T*α*4        aa 59--79      QMEAE**pS**I**pSpSpS**EEIVPN**pS**VEQK   2720.90            3680
  T*α*5        aa 37--58      VNEL**pS**KDIG**pS**E**pS**TEDQAMEDIK    2678.02            3840
  T*α*6        aa 138--149    TVDME**pS**TEVFTK                        1466.60            −210
  T*α*7        aa 46--70      NANEEEYSIG**pSpSpS**EE**pS**AEVATEEVK    3008.02            7100
  T*α*8        aa 1--21       KNTMEHV**pSpSpS**EESII**pS**QETYK        2747.00            2810
  T*α*9        aa 2--21       NTMEHV**pSpSpS**EESII**pS**QETYK         2618.91            2350
  T*β*1        aa 33 --48     FQ**pS**EEQQQTEDELQDK                    2061.82            6200
  T*β*2        aa 1--25       RELEELNVPGEIVE**pS**L**pSpSpS**EESITR    3122.26            −220
  T10          aa 81--91      ALNEINQFYQK                              1367.70            −750
  T4           aa 23--34      FFVAPFPEVFGK                             1384.73            −5530
  T3           aa 8--22       HQGLPQEVLNENLLR                          1759.59            −590
  T11          aa 91--100     YLGYLEQLLR                               1267.71            −6480
  T18          aa 132--150    EPMIGVNQELAYFYPELFR                      2316.14            −6900
  **p**T       ---            VNQIG**pT**LSESIK                        1368.44            −310
  **p**Y       ---            SGSLHRI**pY**THQS                        1465.48            2300

\*Phosphopeptides in tryptic digest of *β*casein and *α*casein are denoted as T*β*1\~2 and T*α*1\~9, respectively. The sites of phosphorylation are indicated with the letter "**p**" in the listed peptide sequences. T3, T4, T11, and T18 are nonphosphorylated peptide from *α*casein S1. T10 is a nonphosphorylated peptide from *α*-casein S2. **p**T and **p**Y are the synthesized standard phosphopeptides. \[M+H\]^+^ denotes the theoretical monoisotopic *m/z* mass. "B+B" means Bull and Breese Index for peptides calculated by the Masslynx software (Waters/Micromass).
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